Advances in low grade lymphoma over the past 40 years

Nathan Fowler, MD from the University of Texas MD Anderson Cancer Center, Houston, TX talks about the history of chemotherapy and advances in low grade lymphoma.

Dr Fowler explains that in the last 30-40 years, we have seen an improvement in survival of patients with low grade lymphoma every decade and today, most patients will never die of follicular lymphoma. He points out that we now have to pay attention to long-term toxicity and the financial burden associated with the new drug regimens. Dr Fowler also mentions how new regimens such as lenalidomide, rituximab, and ibrutinib may ultimately lead to a cure or prolonged remissions.
Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.

Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.

source Video Journal of Hematological Oncology

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: